INNOVATIVEPHAR：InterimReport2024-2025.pdf

1、(Incorporated in the Cayman Islands and continued in Bermuda with limited liability)(於開曼群島註冊成立並於百慕達存續之有限公司)(Stock Code 股份代號：399)INTERIM REPORT2024/25中期報告(Incorporated in the Cayman Islands and continued in Bermuda with limited liability)(於開曼群島註冊成立並於百慕達存續之有限公司)(Stock Code 股份代號：399)CMYCMMYCYCMYKInnova

2、tivePharmBio IR2024-25 Cover V01_OP.pdf 1 19/12/2024 下午5:262Corporate Information公司資料4Management Discussion and Analysis管理層討論及分析12Other Information Provided in Accordance with the Listing Rules根據上市規則披露之其他資料18Condensed Consolidated Statement of Profit or Loss and Other Comprehensive Income簡明綜合損益及其他全面

3、收益表20Condensed Consolidated Statement of Financial Position簡明綜合財務狀況表23Condensed Consolidated Statement of Changes in Equity簡明綜合權益變動表25Condensed Consolidated Statement of Cash Flows簡明綜合現金流量表26Notes to the Condensed Consolidated Financial Statements簡明綜合財務報表附註Contents 目錄Corporate Information公司資料2INNOVA

4、TIVE PHARMACEUTICAL BIOTECH LIMITED 2024/25 Interim ReportBOARD OF DIRECTORSExecutive DirectorsGao Yuan XingTang RongCheng Tak YiuNon-executive DirectorsJiang Nian(Chairman)Xiao YanWu YanminIndependent non-executive DirectorsChen WeijunWang RongliangChen JinzhongAudit CommitteeChen Weijun(Chairman)W

5、ang RongliangChen JinzhongRemuneration CommitteeWang Rongliang(Chairman)Jiang NianChen JinzhongNomination CommitteeJiang Nian(Chairman)Wang RongliangChen JinzhongHONORARY CHAIRMANMao YuminCOMPANY SECRETARYPoon Hon YinREGISTERED OFFICEClarendon House2 Church StreetHamilton HM 11,Bermuda董事會執行董事高源興唐榕鄭德

6、耀非執行董事蔣年（主席）肖焱鄔燕敏獨立非執行董事陳偉君王榮樑陳金中審核委員會陳偉君（主席）王榮樑陳金中薪酬委員會王榮樑（主席）蔣年陳金中提名委員會蔣年（主席）王榮樑陳金中名譽主席毛裕民公司秘書潘漢彥註冊辦事處Clarendon House2 Church StreetHamilton HM 11,BermudaCorporate Information公司資料32024/25年中期報告 領航醫藥及生物科技有限公司PRINCIPAL PLACE OF BUSINESS IN HONG KONGUnit 2002,20th floorOn Hong Commercial Building145 H